Gf Fund Management Co. Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
Search and click to pin securities to the top
Page 20 of 34
SL GREEN REALTY CORP
Shares:
1359(+15.4%)
Value:
$78.4M(-2.0%)
Sabra Health Care REIT, Inc.
Shares:
4481(+5.3%)
Value:
$78.3M(+6.2%)
Scholar Rock Holding Corp
Shares:
2396(+21.9%)
Value:
$77.0M(-9.3%)
EPR PROPERTIES
Shares:
1434(+4.2%)
Value:
$75.4M(+23.8%)
CRISPR Therapeutics AG
Shares:
2186(+22.0%)
Value:
$74.4M(+5.5%)
Protagonist Therapeutics, Inc
Shares:
1526(+22.0%)
Value:
$73.8M(+52.8%)
Merus N.V.
Shares:
1753(+21.9%)
Value:
$73.8M(+22.0%)
Akero Therapeutics, Inc.
Shares:
1787(+21.9%)
Value:
$72.3M(+77.4%)
Legend Biotech Corp
Shares:
2092(+22.0%)
Value:
$71.0M(+27.2%)
TANGER INC.
Shares:
2097(+5.5%)
Value:
$70.9M(+4.5%)
ACADIA PHARMACEUTICALS INC
Shares:
4260(+21.9%)
Value:
$70.8M(+10.4%)
Sweetgreen, Inc.
Shares:
2824
Value:
$70.7M
Apellis Pharmaceuticals, Inc.
Shares:
3185(+21.9%)
Value:
$69.7M(-16.4%)
KILROY REALTY CORP
Shares:
2124(+4.8%)
Value:
$69.6M(-15.1%)
Amneal Pharmaceuticals, Inc.
Shares:
7934(+21.9%)
Value:
$66.5M(+29.0%)
Alvotech
Shares:
6832(+21.9%)
Value:
$66.1M(-10.9%)
Xenon Pharmaceuticals Inc.
Shares:
1952(+21.9%)
Value:
$65.5M(+4.3%)
Immunovant, Inc.
Shares:
3758(+21.9%)
Value:
$64.2M(-15.9%)
NATIONAL HEALTH INVESTORS INC
Shares:
860(+2.4%)
Value:
$63.5M(+9.1%)
AMICUS THERAPEUTICS, INC.
Shares:
7651(+21.9%)
Value:
$62.4M(+5.6%)